Revenue
41.6 thousand USD
2026 Q1 · USD
Exact inputs and evidence
- Revenue: 41605 USD Source
Market value is not computed: no listed ticker is recorded for this company.
Annual consolidated revenue for 2025: about USD 1.742M, using the latest reported figures. The previous period, 2024, was about USD 9.262M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-18.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
45695 USD
308306016 shares
6,146.29% · 303 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
677 thousand USD
2025-04-01 – 2026-03-31
-7.12 million USD
2025-04-01 – 2026-03-31
-5 million USD
2025-04-01 – 2026-03-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-05-27.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 9.26 million
–
Current period
USD 1.74 million
–
1742360 − 9261583 = -7519223 USD
9261583 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1742360 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 13.65 million
–
Current period
−USD 11.99 million
–
-11986754 − -13653340 = 1666586 USD
-13653340 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-11986754 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 5.93 million
–
Current period
−USD 3.99 million
–
-3985013 − -5934771 = 1949758 USD
-5934771 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-3985013 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | 18621344 | 20394458 Derived | -1773114 | 688011 Derived | -2461125 | -2505733 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 8932751 | 14971171 Derived | -6038420 | 1299751 Derived | -7338171 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 9261583 | 19609467 Derived | -10347884 | 3305456 Derived | -13653340 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 1742360 | 8894681 Derived | -7152321 | 4834433 Derived | -11986754 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Revenue | 18621344 |
|
| 2023 | Revenue | 8932751 |
|
| 2024 | Revenue | 9261583 |
|
| 2025 | Revenue | 1742360 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | -52% |
|
| 2024 | Year over year | 3.7% |
|
| 2025 | Year over year | -81.2% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Operating margin | -9.5% |
|
| 2023 | Operating margin | -67.6% |
|
| 2024 | Operating margin | -111.7% |
|
| 2025 | Operating margin | -410.5% |
|
| 2022 | Net margin | -13.2% |
|
| 2023 | Net margin | -82.1% |
|
| 2024 | Net margin | -147.4% |
|
| 2025 | Net margin | -688% |
|
| 2022 | Free cash flow margin | -13.5% |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Operating cash flow | -2452839 |
|
| 2023 | Operating cash flow | -1680128 |
|
| 2024 | Operating cash flow | -5934771 |
|
| 2025 | Operating cash flow | -3985013 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Free cash flow | -2505733 |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Liabilities / assets | 97% |
|
| 2023 | Liabilities / assets | 147.3% |
|
| 2024 | Liabilities / assets | 226.8% |
|
| 2025 | Liabilities / assets | 155.3% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Current assets / current liabilities | 0.8× |
|
| 2023 | Current assets / current liabilities | 0.5× |
|
| 2024 | Current assets / current liabilities | 0.26× |
|
| 2025 | Current assets / current liabilities | 0.04× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | −USD 2.46 million Exact valueExact value: -2461125 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.45 million Exact valueExact value: -2452839 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 52,894 Exact valueExact value: 52894 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.51 million Calculation and evidence-2452839 − 52894 USD Exact free cash flow: -2505733 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 7.34 million Exact valueExact value: -7338171 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.68 million Exact valueExact value: -1680128 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 13.65 million Exact valueExact value: -13653340 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.93 million Exact valueExact value: -5934771 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 11.99 million Exact valueExact value: -11986754 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.99 million Exact valueExact value: -3985013 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
16 filings · 1,000 latest values · 1,000 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001947861, 1947861, edgar:1947861
Also known as LBBB Merger Corp., NATURE’S MIRACLE HOLDING INC., Nature's Miracle Holding Inc., Nature’s Miracle Holding Inc.